This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
CHADDS FORD, Pa.,
Sept. 28, 2012 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today announced the appointment of
Jill D. Smith to the company's board of directors. Ms. Smith, an international business leader for more than 25 years, including 16 years as a CEO of private and public companies in the technology and information services markets, was most recently chairman, CEO and president of DigitalGlobe Inc., a provider of satellite imagery products and services to governments and companies worldwide. Her appointment brings the number of Endo board members to 10.
Roger Kimmel, chairman of the board of Endo, stated: "We are pleased to have Jill join our board and bring her vast international and technology and information services experience to our company. We look forward to Jill's contributions to our future success as Endo continues to grow its businesses by focusing on the unmet needs of patients along the pain management and urology care pathways."
As an independent director, Ms. Smith currently serves on the board of SoundBite Communications, Inc., a leading provider of cloud-based customer communications. She has served on the corporate boards of
Germany-based Elster Group, Smith & Hawken and DigitalGlobe (prior to her appointment as Chairman and CEO). In addition, Ms. Smith is a member of the executive committee for the Women's Cancer Program at Dana Farber, among other past professional and trade association board positions.
Endo Health Solutions Inc. (Endo) is a U.S.-based diversified healthcare company that is redefining healthcare value by finding solutions for the unmet needs of patients along care pathways for pain management and urology. Through our operating companies: AMS, Endo Pharmaceuticals, HealthTronics and Qualitest, Endo is dedicated to improving care through a combination of branded products, generics, devices, technology and services that creates maximum value for patients, providers and payers alike. Learn more at
Safe Harbor Statement